FDAsafety guidance95% confidence
Newly Added Guidance Documents
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to FDA Issues Guidance on Postapproval Pregnancy Safety Studies; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.
Supporting Context
- Therapeutic area
- General · Drug Safety
- Sub-indication
- General
Related signal: FDA Issues Guidance on Postapproval Pregnancy Safety Studies